Literature DB >> 25968124

Trends in Antihypertensive Medication Use and Blood Pressure Control Among Adults With Hypertension in Germany.

Giselle Sarganas1, Hildtraud Knopf2, Daniel Grams2, Hannelore K Neuhauser3.   

Abstract

BACKGROUND: Hypertension is a major risk factor for morbidity and mortality, therefore its control is of great importance. In this study we compare the use of antihypertensive medication among adults with hypertension in Germany 1998 and 2008-2011 and determine factors associated with use and control.
METHODS: Data from German Health Examination Surveys (GNHIES98 1998, n = 7,124 and DEGS1 2008-2011 n = 7,988, age 18-79 years) including standardized blood pressure (BP) measurements and Anatomical Therapeutic Chemical (ATC) medication codes were analyzed.
RESULTS: The use of antihypertensive medication among adults with hypertension in Germany increased from 54% to 72% in 1 decade. In 2008-2011, 67% of users were treated with polytherapy. The most commonly used antihypertensive class in 1998 was diuretics (43%) and in 2008-2011 beta-blockers (54%). Ramipril and metoprolol are currently the most commonly used monotherapy agents, while ramipril in combination with hydrochlorothiazide is the most frequent polytherapy. Being a woman, older age, having statutory health insurance, diabetes, coronary heart disease (CHD), stroke, and obesity were positively associated with antihypertensive use. The control rate among treated increased from 42% to 72%. Young women (18-54 years) had better control compared to older women or to men. Having CHD or stroke was positively associated with BP control.
CONCLUSIONS: Increased and improved antihypertensive use might be a main contributor to the decrease in BP observed in Germany in the last decade. However, there are still socio-demographic and health disparities in hypertension treatment and control. © American Journal of Hypertension, Ltd 2015. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Germany.; antihypertensive; blood pressure; control; factors-associated; hypertension; treatment; trends

Mesh:

Substances:

Year:  2015        PMID: 25968124     DOI: 10.1093/ajh/hpv067

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  22 in total

1.  Hypertension in Germany.

Authors:  Hannelore Neuhauser; Claudia Diederichs; Heiner Boeing; Stephan B Felix; Claus Jünger; Roberto Lorbeer; Christine Meisinger; Annette Peters; Henry Völzke; Cornelia Weikert; Philipp Wild; Marcus Dörr
Journal:  Dtsch Arztebl Int       Date:  2016-12-02       Impact factor: 5.594

Review 2.  [Telemonitoring and eHealth for arterial hypertension : Status quo and perspectives].

Authors:  C Beger; H Haller; F P Limbourg
Journal:  Internist (Berl)       Date:  2021-02-12       Impact factor: 0.743

3.  Time Trends in Cardiometabolic Risk Factors in Adults.

Authors:  Jonas D Finger; Markus A Busch; Yong Du; Christin Heidemann; Hildtraud Knopf; Ronny Kuhnert; Thomas Lampert; Gert B M Mensink; Hannelore K Neuhauser; Angelika Schaffrath Rosario; Christa Scheidt-Nave; Anja Schienkiewitz; Julia Truthmann; Bärbel-Maria Kurth
Journal:  Dtsch Arztebl Int       Date:  2016-10-21       Impact factor: 5.594

4.  Potential Impact of 2017 American College of Cardiology/American Heart Association Hypertension Guideline on Contemporary Practice: A Cross-Sectional Analysis From NCDR PINNACLE Registry.

Authors:  Aliza Hussain; Salim S Virani; Luke Zheng; Ty J Gluckman; William B Borden; Frederick A Masoudi; Thomas M Maddox
Journal:  J Am Heart Assoc       Date:  2022-06-03       Impact factor: 6.106

5.  The persisting gender gap in hypertension management and control in Germany: 1998 and 2008-2011.

Authors:  Giselle Sarganas; Hannelore K Neuhauser
Journal:  Hypertens Res       Date:  2016-01-28       Impact factor: 3.872

6.  Antihypertensive Treatment Patterns and Blood Pressure Control in Older Adults: Results from the Berlin Aging Study II.

Authors:  Maximilian König; Maik Gollasch; Adrian Rosada; Ilja Demuth; Dominik Spira; Elisabeth Steinhagen-Thiessen
Journal:  Drugs Aging       Date:  2018-11       Impact factor: 3.923

7.  Drug treatment of hypertension in Sweden in relation to sex, age, and comorbidity.

Authors:  Fredrik Wallentin; Björn Wettermark; Thomas Kahan
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-12-08       Impact factor: 3.738

8.  Untreated, Uncontrolled, and Apparent Resistant Hypertension: Results of the German Health Examination Survey 2008-2011.

Authors:  Giselle Sarganas; Hannelore K Neuhauser
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-08-02       Impact factor: 3.738

9.  Persistence to antihypertensive drug classes: A cohort study using the Swedish Primary Care Cardiovascular Database (SPCCD).

Authors:  Miriam Qvarnström; Thomas Kahan; Helle Kieler; Lena Brandt; Jan Hasselström; Kristina Bengtsson Boström; Karin Manhem; Per Hjerpe; Björn Wettermark
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

10.  Effectiveness of a Fixed-Dose, Single-Pill Combination of Perindopril and Amlodipine in Patients with Hypertension: A Non-Interventional Study.

Authors:  Susanne V Fleig; Bettina Weger; Hermann Haller; Florian P Limbourg
Journal:  Adv Ther       Date:  2018-03-01       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.